1. Ben-Moshe, Shani, Shapira, Yonatan, Moor, Andreas E, Bahar Halpern, Keren, Itzkovitz, Shalev. 2019. Spatial sorting enables comprehensive characterization of liver zonation. In Nature metabolism, 1, 899-911. doi:10.1038/s42255-019-0109-9. https://pubmed.ncbi.nlm.nih.gov/31535084/
2. Chen, Wen, Liu, Zhiwen, Mai, Wenli, You, Xiaolong, Qin, Lei. . FZD8 Indicates a Poor Prognosis and Promotes Gastric Cancer Invasion and Metastasis via B-Catenin Signaling Pathway. In Annals of clinical and laboratory science, 50, 13-23. doi:. https://pubmed.ncbi.nlm.nih.gov/32161008/
3. Li, Qiji, Ye, Liping, Zhang, Xin, Song, Libing, Peng, Xinsheng. 2017. FZD8, a target of p53, promotes bone metastasis in prostate cancer by activating canonical Wnt/β-catenin signaling. In Cancer letters, 402, 166-176. doi:10.1016/j.canlet.2017.05.029. https://pubmed.ncbi.nlm.nih.gov/28602974/
4. Boyd, J Lomax, Skove, Stephanie L, Rouanet, Jeremy P, Wray, Gregory A, Silver, Debra L. 2015. Human-chimpanzee differences in a FZD8 enhancer alter cell-cycle dynamics in the developing neocortex. In Current biology : CB, 25, 772-779. doi:10.1016/j.cub.2015.01.041. https://pubmed.ncbi.nlm.nih.gov/25702574/
5. Mu, Qinghui, Ha, Andrew, Santos, Antonio J M, Garcia, K Christopher, Kuo, Calvin J. 2024. FZD5 controls intestinal crypt homeostasis and colonic Wnt surrogate agonist response. In Developmental cell, 60, 342-351.e5. doi:10.1016/j.devcel.2024.10.022. https://pubmed.ncbi.nlm.nih.gov/39579768/
6. Al-Zahrani, Maryam H, Assidi, Mourad, Pushparaj, Peter Natesan, Buhmeida, Abdelbaset, Abu-Elmagd, Muhammad. 2023. Expression pattern, prognostic value and potential microRNA silencing of FZD8 in breast cancer. In Oncology letters, 26, 477. doi:10.3892/ol.2023.14065. https://pubmed.ncbi.nlm.nih.gov/37809047/